Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study

---

AYDIN N. N., AKSOY F., YAVUZ İ., Iskender S., YILDIRIM A. A., Yildiz I. E., ...More

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.25, no.3, pp.105-108, 2019 (ESCI, TRDizin)

• Publication Type: Article / Article
• Volume: 25 Issue: 3
• Publication Date: 2019
• Doi Number: 10.4274/vhd.galenos.2019.2019.0025
• Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
• Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Page Numbers: pp.105-108
• Karadeniz Technical University Affiliated: Yes

Abstract

Objectives: Hepatitis C virus (HCV) infection is common among hemodialysis (HD) patients and is associated with increased morbidity and mortality. New generation direct-acting antiviral (DAA) agents are safe and effective in treatment HCV infection in HD patients. The aim of this a multi-center study was to assess the efficacy of DAAs in HD patients with HCV infection.